Trials / Conditions / Unresectable Pancreatic Adenocarcinoma

Unresectable Pancreatic Adenocarcinoma

11 registered clinical trials studyying Unresectable Pancreatic Adenocarcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic NCT06998940	SWOG Cancer Research Network	Phase 3
Recruiting	TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, NCT07189195	University of California, Davis	Phase 1
Recruiting	Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally A NCT06381154	Mayo Clinic	Phase 2
Withdrawn	Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-adva NCT06398587	OHSU Knight Cancer Institute	Phase 2
Recruiting	LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia NCT06073431	University of Rochester	—
Active Not Recruiting	PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvan NCT06132087	University of Southern California	N/A
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumor NCT04514497	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Trea NCT04616534	National Cancer Institute (NCI)	Phase 1
Terminated	Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial NCT03878524	OHSU Knight Cancer Institute	Phase 1
Completed	Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients NCT03490604	Centre Hospitalier Universitaire Dijon	—
Active Not Recruiting	A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors NCT02498613	National Cancer Institute (NCI)	Phase 2